-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPresentación
Análisis del mercado farmacéutico con efecto del COVID-19 - Semana 26
Jul 09, 2020
Una semana más (semana 26) continúa la tendencia negativa del mercado farmacéutico y del mercado Consumer Health que se ha visto durante los meses de mayo y junio. Concretamente, ambos mercados llevan aproximadamente 10 semanas sistemáticamente por debajo de los niveles del año pasado pese a los crecimientos que vimos durante el momento de mayor crisis sanitaria. En particular, ahora los valores en el acumulado desde el inicio del Covid-19 en España hasta la semana 26, muestran un balance equivalente a los números de 2019. Es importante seguir de cerca su evolución de cara a evaluar una recuperación en términos de crecimiento. A continuación, un breve resumen de los puntos que destacan esta semana:
- La actividad total en la farmacia mantiene una tendencia plana frente a las semanas anteriores si atendemos al número medio de tickets (-8,2% con respecto a la misma semana del año pasado). Sin embargo, el valor medio del ticket muestra crecimientos de un 9% en comparación a la misma semana de 2019.
- La semana 26 confirma el punto de inflexión para el mercado de prescripción que vimos la semana anterior, donde el efecto positivo que tuvo el Covid-19 sobre el crecimiento durante las semanas de mayor crisis ya ha quedado diluido (w6-w26 con crecimientos de 0,4% en 2020 vs. 2019). Lo cierto es que este segmento del mercado lleva 10 semanas seguidas por debajo de niveles de 2019 (-7,8% w26 2020 vs 2019), donde las clases relacionadas con el aparato respiratorio y sistema locomotor son las que están conduciendo este decrecimiento.
- La situación para Consumer Health es similar, donde los crecimientos en valores en el mismo periodo acumulado de 2020 respecto 2019 se han visto mermados por el decrecimiento generalizado de todos los segmentos que componen este mercado durante las últimas semanas. En particular, esta semana los valores 2020 se sitúan por debajo de los del año pasado de nuevo, y lo hacen para todas las categorías salvo el subsegmento de NUT que no corresponde a nutrición infantil. PEC dermocosmética es el subsegmento más castigado, con un decrecimiento de 11,6% w26 2020 vs 2019. Es importante mencionar que, con el objetivo de comparar las tendencias de los mercados tal y como los conocemos, se han excluido los productos de mascarillas, geles hidroalcohólicos y guantes procedentes de fabricantes que no operan en España.
- El Mercado Covid-19 se mantiene estable respecto a la semana anterior, con decrecimientos de -6% incluso respecto a niveles de 2019. Este comportamiento ha sido similar durante las últimas 3 semanas, donde el decrecimiento ha sido conducido por todas las categorías salvo prevención higiene (mascarillas, guantes y geles hidroalcóholicos). De nuevo, los productos de mascarillas, geles hidroalcohólicos y guantes procedentes de fabricantes que no operan en España han sido excluidos del informe.
- El canal online se mantiene una semana más al alza, con crecimientos del 159% en la w26 2020 con respecto a la misma semana del año anterior.